The Impact of Isotretinoin Therapy on the Nasal Skin Thickness and Elasticity : An Ultrasonography and Elastography Based Assessment in Relation to Dose and Duration of Therapy
© 2021. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery..
BACKGROUND: This study aimed to evaluate the impact of isotretinoin therapy on the nasal skin thickness and elasticity with regard to implications for rhinoplasty METHODS: A total of 40 acne vulgaris patients (mean±SD age: 20.9 ± 3.0 years, 65.0% were females) initiating oral isotretinoin treatment (0.25 mg/kg/day, n = 16 or 0.5 mg/kg/day, n = 24) were included in this prospective 4-month isotretinoin follow-up study. Ultrasonography assessments regarding nasal skin thickness (dermis and soft tissue) and elastography were repeated at second and fourth months of treatment.
RESULTS: No significant difference was noted between isotretinoin dose groups in terms of second month and fourth month nasal skin thickness (dermis and soft tissue) values measured at any region. Each dose revealed significant decrease in dermis and soft tissue thickness from baseline at any region (p ranged < 0.001 to < 0.001), while only fourth month values at nasal tip and second month values at rhinion for dermis and only fourth month values at rhinion and glabella for subcutaneous tissue significantly differed from baseline (p < 0.01 for each) in the 0.25 mg and 0.50 mg dose groups, respectively. Elastography values at fourth month of isotretinoin treatment were significantly higher than pre-treatment and second month values in both 0.25 mg (90.4 ± 20.6 vs. 59.5 ± 21.8 and 76.4 ± 22.9, p < 0.01 for each) and 0.5 mg (86.7 ± 20.6 vs. 61.8 ± 23.2 and 76.9±24, p < 0.01 for each) dose groups.
CONCLUSIONS: In conclusion, our findings revealed the association of isotretinoin treatment with a significant decrease in dermis and subcutaneous soft tissue thickness measured at each anatomical landmark, regardless of the treatment dose.
LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
| Errataetall: |
CommentIn: Aesthetic Plast Surg. 2022 Aug;46(4):1771-1772. - PMID 35013753 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
Aesthetic plastic surgery - 46(2022), 4 vom: 01. Aug., Seite 1760-1770 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yigit, Enes [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Dermis |
|---|
| Anmerkungen: |
Date Completed 28.09.2022 Date Revised 17.11.2022 published: Print-Electronic CommentIn: Aesthetic Plast Surg. 2022 Aug;46(4):1771-1772. - PMID 35013753 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00266-021-02663-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333578759 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333578759 | ||
| 003 | DE-627 | ||
| 005 | 20231225221930.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00266-021-02663-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1111.xml |
| 035 | |a (DE-627)NLM333578759 | ||
| 035 | |a (NLM)34820691 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yigit, Enes |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Impact of Isotretinoin Therapy on the Nasal Skin Thickness and Elasticity |b An Ultrasonography and Elastography Based Assessment in Relation to Dose and Duration of Therapy |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.09.2022 | ||
| 500 | |a Date Revised 17.11.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Aesthetic Plast Surg. 2022 Aug;46(4):1771-1772. - PMID 35013753 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery. | ||
| 520 | |a BACKGROUND: This study aimed to evaluate the impact of isotretinoin therapy on the nasal skin thickness and elasticity with regard to implications for rhinoplasty METHODS: A total of 40 acne vulgaris patients (mean±SD age: 20.9 ± 3.0 years, 65.0% were females) initiating oral isotretinoin treatment (0.25 mg/kg/day, n = 16 or 0.5 mg/kg/day, n = 24) were included in this prospective 4-month isotretinoin follow-up study. Ultrasonography assessments regarding nasal skin thickness (dermis and soft tissue) and elastography were repeated at second and fourth months of treatment | ||
| 520 | |a RESULTS: No significant difference was noted between isotretinoin dose groups in terms of second month and fourth month nasal skin thickness (dermis and soft tissue) values measured at any region. Each dose revealed significant decrease in dermis and soft tissue thickness from baseline at any region (p ranged < 0.001 to < 0.001), while only fourth month values at nasal tip and second month values at rhinion for dermis and only fourth month values at rhinion and glabella for subcutaneous tissue significantly differed from baseline (p < 0.01 for each) in the 0.25 mg and 0.50 mg dose groups, respectively. Elastography values at fourth month of isotretinoin treatment were significantly higher than pre-treatment and second month values in both 0.25 mg (90.4 ± 20.6 vs. 59.5 ± 21.8 and 76.4 ± 22.9, p < 0.01 for each) and 0.5 mg (86.7 ± 20.6 vs. 61.8 ± 23.2 and 76.9±24, p < 0.01 for each) dose groups | ||
| 520 | |a CONCLUSIONS: In conclusion, our findings revealed the association of isotretinoin treatment with a significant decrease in dermis and subcutaneous soft tissue thickness measured at each anatomical landmark, regardless of the treatment dose | ||
| 520 | |a LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Dermis | |
| 650 | 4 | |a Dose | |
| 650 | 4 | |a Elastography | |
| 650 | 4 | |a Isotretinoin | |
| 650 | 4 | |a Nasal landmarks | |
| 650 | 4 | |a Nasal skin thickness | |
| 650 | 4 | |a Soft tissue | |
| 650 | 4 | |a Ultrasonography | |
| 650 | 7 | |a Isotretinoin |2 NLM | |
| 650 | 7 | |a EH28UP18IF |2 NLM | |
| 700 | 1 | |a Rakici, Ibrahim Taskin |e verfasserin |4 aut | |
| 700 | 1 | |a Seden, Nihal |e verfasserin |4 aut | |
| 700 | 1 | |a Manav, Vildan |e verfasserin |4 aut | |
| 700 | 1 | |a Kaygisiz, Ismail |e verfasserin |4 aut | |
| 700 | 1 | |a Yigit, Ozgur |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Aesthetic plastic surgery |d 1976 |g 46(2022), 4 vom: 01. Aug., Seite 1760-1770 |w (DE-627)NLM012961906 |x 1432-5241 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2022 |g number:4 |g day:01 |g month:08 |g pages:1760-1770 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00266-021-02663-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2022 |e 4 |b 01 |c 08 |h 1760-1770 | ||